Search from website

Human IgG1-lambda antibody to SARS CoV-2 NP (clone 43E5)

 

Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 43E5. 10% gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 43E5 (+DTT). Lane 2. Size marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 43E5 (-DTT).

       

Figure 2. HPLC analytical SEC for final product.

       

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

       

Figure 4. Octet RED96e analysis, antibody was loaded on sensor for capture of Nucleocapsid protein in different concentrations (200, 100, 50 and 25 nM).

Select volume:

Quantity:

Catalogue #

R1-167-100

Name

Human IgG1-lambda antibody to SARS CoV-2 NP (clone 43E5)

Target

Nucleocapsid protein SARS-CoV-2

Target Description

Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based Icosagen Cell factory Ltd. proprietary suspension cell line

Clonality

Human monoclonal

Clone

43E5

Class

hIgG1

Reactivity

SARS-CoV-2 Nucleocapsid protein

Dissociation constant (KD)

2.23 x 10-9 M

Application

ELISA

Kd:

2.23 x 10-9 M

ELISA:

indirect ELISA 0,02-0,04 ng/ml

Purification

Protein A affinity chromatography following gel filtration

Buffer

PBS pH 7.4

Shipping

Shipped at ambient temperature.

Storage

Store at -20 °C to -70 °C long term. Avoid multiple freeze-thaw cycles.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com
error:
Shopping Cart